BUY Aurobindo PharmaSandip Sabharwal

bySandip SabharwalHorizon: NA (inferred Intraday)22 Jul 2026, 7:23 am ISTvia CNBC Awaaz.

Entry₹1,564Inferred
Target₹1,600
Total upside +2.30% (call closed)
Stop loss₹1,560-0.26% risk
Exit₹1,56022 Jul 2026, 9:15 am
Stop-loss hit-0.26%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Jul 2026
1 supporting0 opposing
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.